Atlantis Healthcare Limited or any third party it has authorised (“Atlantis”) is the organisation that collects and processes all personal information that you supply as part of your registration for the MS One to One programme, as well as any other data you may volunteer to share under this programme (“Personal Information”). Atlantis, is the data processor and it does this on behalf of Sanofi Genzyme the data controller.

Your Personal Information will be used for the purpose of processing your registration and, if you have agreed to, to contact you for participation in any surveys. Atlantis will not share your Personal Data with Sanofi Genzyme or third parties, unless you have granted permission to do so or when this is required by law. If, with your consent, any of your Personal Information is shared with Sanofi Genzyme, Sanofi Genzyme will treat this information in accordance with applicable data protection laws.

Atlantis may share your Personal Information in an aggregated and/or anonymised format (meaning without disclosing your identity) with Sanofi Genzyme and third parties designated by Sanofi Genzyme, e.g. for reporting or evaluation purposes.

Atlantis will maintain appropriate technical and organisational measures against unauthorised or unlawful access to and processing of your Personal Information, and further against accidental loss, alteration, disclosure or destruction of, or damage to, such Personal Information.

Your Personal Information will be held on a database within the EU, however, may be transferred to a third country outside the European Economic Area ("EEA"). It may also be processed by staff operating outside the EEA who work for Atlantis. By submitting your Personal Data, you agree to this transfer, storing or processing. 

If the MS One to One programme ends or if you decide to withdraw from the programme, your Personal Information will be deleted (excluding anonymised data) by Atlantis as soon as reasonably possible but in any event within 3 months, unless in cases where it is required by law to keep these data, e.g. in cases where Sanofi Genzyme is obliged to keep the data for reasons of drug safety obligations as mandated by law.

If Atlantis ceases hosting www.msonetoone.ie or providing services on behalf of Sanofi Genzyme, you will agree that Atlantis may i) transfer your Personal Information to the successor appointed by Sanofi Genzyme and ii) continue to hold your Personal Information in its database until the moment of such transfer. If such transfer does not take place within 12 months, Atlantis will delete your Personal Information. In case such transfer occurs, Sanofi Genzyme will ensure that the company who takes over from Atlantis (‘the successor’) will be bound and operating according to the same strict standards for data protection as Atlantis.

Contact Us:

Should you wish to correct your Personal Information, request its deletion or stop its processing kindly contact the MS One to One programme by email: nurses@atlantishealthcare.com or write to: MS One to One, c/o Atlantis Healthcare, 2nd Floor, Building 5, Chiswick Park, 566 Chiswick High Road, London W4 5YA. Alternatively, you can write to the address in section 6 of our Terms and Conditions.

MS One to One is administered by:

Atlantis Healthcare
2nd Floor, Building 5,
Chiswick Park,
566 Chiswick High Road,
London W4 5YA
Phone 1800 812 166
nurses@atlantishealthcare.com

MS One to One is developed and within editorial control of:

Genzyme Therapeutics Ltd,
4620 Kingsgate, Cascade Way,
Oxford Business Park South,
Oxford OX4 2SU

MS.enquiries@ Sanofi Genzyme.com

GZUK.MS.16.03.0174. Date of Preparation: April 2016